Sutro Biopharma (STRO) PT Lowered to $20 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $21.31 +0.05%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Sutro Biopharma (NASDAQ: STRO) to $20.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sutro Biopharma (STRO) PT Lowered to $34 at Citizens on Q2 Revenue Miss
- Sutro Biopharma posts Q2 loss, reports early STRO-004 trial data
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$695 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
